top of page

Sciotide LAI Powder and Solvent for Prolonged-Release Suspension for Injection 30mg/vial

Product details

Registration number: SIN17379P

Classification: Prescription Only

Active ingredients: Octreotide Acetate equivalent to Octreotide

Strength: 30.0mg/vial

Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION,EXTENDED RELEASE

Route: INTRAMUSCULAR

Registrant: SCIGEN PTE. LTD.

ATC code: H01CB02

HSA approval date: 31 October 2025

Manufacturer(s):

  • Pharmathen International S.A. (Powder and Solvent)
  • Pharmathen International S.A. (Powder and Solvent)

Manufacturing country/countries: GREECE

What are the HSA registration number and classification for Sciotide LAI Powder and Solvent for Prolonged-Release Suspension for Injection 30mg/vial?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN17379P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for Sciotide LAI Powder and Solvent for Prolonged-Release Suspension for Injection 30mg/vial?

According to the HSA dataset updated 7 August 2026:

Active ingredients: Octreotide Acetate equivalent to Octreotide

Strength: 30.0mg/vial

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for Sciotide LAI Powder and Solvent for Prolonged-Release Suspension for Injection 30mg/vial?

According to the HSA dataset updated 7 August 2026:

Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION,EXTENDED RELEASE

Route: INTRAMUSCULAR

Source for this answer

Who is the recorded registrant for Sciotide LAI Powder and Solvent for Prolonged-Release Suspension for Injection 30mg/vial?

According to the HSA dataset updated 7 August 2026:

Registrant: SCIGEN PTE. LTD.

Source for this answer

Which manufacturers and countries are listed for Sciotide LAI Powder and Solvent for Prolonged-Release Suspension for Injection 30mg/vial?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s):

  • Pharmathen International S.A. (Powder and Solvent)
  • Pharmathen International S.A. (Powder and Solvent)

Manufacturing country/countries: GREECE

Source for this answer

Where can I look up Sciotide LAI Powder and Solvent for Prolonged-Release Suspension for Injection 30mg/vial in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN17379P or the exact product name Sciotide LAI Powder and Solvent for Prolonged-Release Suspension for Injection 30mg/vial. The general register link does not preselect this product.

Source for this answer

What are the source dates for this Sciotide LAI Powder and Solvent for Prolonged-Release Suspension for Injection 30mg/vial record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this Sciotide LAI Powder and Solvent for Prolonged-Release Suspension for Injection 30mg/vial record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN17379P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page